Harmon Cyrus sold OLMA
July 24, 2026 · Form 4 insider transaction
Harmon Cyrus sold 12,500 shares of Olema Pharmaceuticals, Inc. at $11.71 per share, a transaction worth $146.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
12,500
Price
$11.71
Total value
$146.4K
InsiderHarmon Cyrus
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 24, 2026
Filing dateJuly 27, 2026
Shares owned after702,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average sale price for the transaction reported was $11.714, and the range of prices were between $11.70 and $11.775. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.